Basilea Pharmaceutica AG
Swiss commercial‑stage biotech specializing in severe bacterial & fungal infections. Portfolio includes approved Cresemba and Zevtera, plus a strong pipeline—fosmanogepix, ceftibuten‑ledaborbactam, BAL2062—and strategic collaborations for growth.
Headquarters: Switzerland (CHE)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Hospitals and Health Care
- Industry: Medical Practices
- Employees: 180
- HQ: Allschwil
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.